Hakkinen J P, Holt W F, Goddard C J, Oates P J, Murphy W R, Maciejko J J, Reiter L A
Department of Metabolic Diseases, Central Research Division, Pfizer Inc., Groton, CT 06340.
Dig Dis Sci. 1991 Dec;36(12):1721-8. doi: 10.1007/BF01296616.
CP-66,948 is a histamine H2-receptor antagonist with gastric antisecretory activity and mucosal protective properties. The affinity of CP-66,948 for the guinea pig atria histamine H2-receptor is 15 times greater than that of cimetidine and seven times greater than that of ranitidine. In vivo, the ED50 value for inhibition of gastric acid secretion in pylorus-ligated rats is 2 mg/kg intraduodenally, and in histamine or pentagastrin-stimulated Heidenhain pouch dogs the antisecretory ED50 values are 0.3 mg/kg per os and 1.0 mg/kg per os, respectively. CP-66,948 also inhibits ethanol-induced gastric hemorrhagic lesions in rats following either oral or systemic administration (ED50 values of 12 mg/kg per os and 6 mg/kg subcutaneously). In addition, the mucosal protective activity is independent of prostaglandin synthesis. CP-66,948 inhibits gastric acid secretion in man, and its mucosal protective activity may provide additional benefits in peptic ulcer therapy.
CP - 66,948是一种具有胃抗分泌活性和粘膜保护特性的组胺H2受体拮抗剂。CP - 66,948对豚鼠心房组胺H2受体的亲和力比西咪替丁高15倍,比雷尼替丁高7倍。在体内,十二指肠内给予幽门结扎大鼠抑制胃酸分泌的ED50值为2mg/kg,在组胺或五肽胃泌素刺激的海登海因小胃犬中,抗分泌ED50值分别为口服0.3mg/kg和1.0mg/kg。口服或全身给药后,CP - 66,948还能抑制大鼠乙醇诱导的胃出血性病变(口服和皮下注射的ED50值分别为12mg/kg和6mg/kg)。此外,其粘膜保护活性与前列腺素合成无关。CP - 66,948可抑制人体胃酸分泌,其粘膜保护活性可能为消化性溃疡治疗带来额外益处。